Rapid and Sustained Influence of Intravenous Zoledronic Acid on Course of Pain and Analgesics Consumption in Patients with Cancer with Bone Metastases: A Multicenter Open-Label Study Over 1 Year
- 30 September 2007
- journal article
- Published by Elsevier BV in Supportive Cancer Therapy
- Vol. 4 (4), 203-210
- https://doi.org/10.3816/sct.2007.n.016
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Molecular mechanisms of action of bisphosphonatesBone, 1999
- Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.Journal of Clinical Oncology, 1998
- Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.Journal of Clinical Oncology, 1998
- Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including RasJournal of Bone and Mineral Research, 1998
- Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.Journal of Clinical Oncology, 1998
- Cancer and BoneEndocrine Reviews, 1998
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesThe New England Journal of Medicine, 1996
- Metabolic effects of pamidronate in patients with metastatic bone diseaseBritish Journal of Cancer, 1996
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaThe New England Journal of Medicine, 1996
- Structure-activity relationships of various bisphosphonatesCalcified Tissue International, 1983